SUDO-550

N/A

Report date: 2024/12/17 17:01:03
NME

Base Information

Drug NameSUDO-550
Drug Alias NameSUDO-550
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsNeurodegenerative DiseasesBrain DiseasesMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSudo Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesSudo Biosciences Inc
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesMultiple Sclerosis
Inactive IndicationsBrain Diseases

Other Information

ATC CodeN/A
Related LinksN/A